Data / Drug companies / Sulfone
Sulfone drugs: 6 drugs from 30 companies in the FDA NDC directory
Sulfone is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 51 products in this class from 30 companies, covering 6 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on July 8, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 30Companies
- 51Products
- 6Drugs by generic name
Drugs in the Sulfone class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Dapsone | 44 | 26 |
| Dapsone gel, 5% | 2 | 2 |
| Dapsone tablets | 2 | 1 |
| Dapsone 100mg | 1 | 1 |
| Dapsone 25mg | 1 | 1 |
| Daspone | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Sun Pharmaceutical Industries, Inc. | 4 | gel; tablet | Generic drugs (ANDA) | June 26, 2019 |
| Westminster Pharmaceuticals, LLC | 4 | tablet | Generic drugs (ANDA) | August 21, 2025 |
| Viona Pharmaceuticals Inc | 3 | tablet; gel | Generic drugs (ANDA) | February 27, 2026 |
| Zydus Lifesciences Limited | 3 | tablet; gel | Generic drugs (ANDA) | February 27, 2026 |
| Alembic Pharmaceuticals Inc. | 2 | gel | Generic drugs (ANDA) | July 1, 2026 |
| Alembic Pharmaceuticals Limited | 2 | gel | Generic drugs (ANDA) | July 1, 2026 |
| Ani Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | January 15, 2018 |
| Chartwell RX, LLC | 2 | tablet | Generic drugs (ANDA) | May 10, 2016 |
| Everest Life Sciences. LLC | 2 | tablet | Generic drugs (ANDA) | September 1, 2024 |
| Macleods Pharmaceuticals Limited | 2 | tablet | Generic drugs (ANDA) | July 8, 2026 |
| NorthStar Rx LLC | 2 | gel | Generic drugs (ANDA) | October 6, 2023 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | August 21, 2025 |
| Rising Pharma Holdings, Inc. | 2 | tablet | Generic drugs (ANDA) | July 20, 2023 |
| Solis Pharmaceuticals Inc. | 2 | tablet | Generic drugs (ANDA) | May 9, 2016 |
| TruPharma, LLC | 2 | gel | Generic drugs (ANDA) | November 20, 2024 |
| Almirall, LLC | 1 | gel | New drug applications (NDA) | September 10, 2019 |
| Amneal Pharmaceuticals LLC | 1 | gel | Generic drugs (ANDA) | October 24, 2023 |
| Amneal Pharmaceuticals NY LLC | 1 | gel | Generic drugs (ANDA) | June 2, 2023 |
| Aurobindo Pharma Limited | 1 | gel | Generic drugs (ANDA) | April 4, 2025 |
| AvKARE | 1 | tablet | Generic drugs (ANDA) | December 10, 2025 |
| AvKARE | 1 | tablet | Generic drugs (ANDA) | March 6, 2024 |
| Boswell Pharmacy Services LLC D/B/A BPS Wholesale | 1 | tablet | Generic drugs (ANDA) | August 30, 2024 |
| Cosette Pharmaceuticals, Inc. | 1 | gel | Generic drugs (ANDA) | May 8, 2023 |
| Coupler LLC | 1 | tablet | Generic drugs (ANDA) | January 31, 2025 |
| Encube Ethicals, Inc. | 1 | gel | Generic drugs (ANDA) | October 16, 2023 |
| Mayne Pharma | 1 | gel | Generic drugs (ANDA) | February 11, 2022 |
| Mayne Pharma Inc. | 1 | gel | Generic drugs (ANDA) | February 14, 2024 |
| Mylan Pharmaceuticals Inc. | 1 | gel | Generic drugs (ANDA) | May 20, 2022 |
| Pacific Pharma, Inc. | 1 | gel | Authorized generics (NDA) | October 18, 2017 |
| Torrent Pharmaceuticals Limited | 1 | gel | Generic drugs (ANDA) | February 10, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 28 | 54.9% |
| Gel | 23 | 45.1% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.